SignatureFD’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $52 | Hold |
23
| – | – | ﹤0.01% | 3458 |
|
|
2026
Q1 | $66 | Hold |
23
| – | – | ﹤0.01% | 3405 |
|
|
2025
Q4 | $74 | Hold |
23
| – | – | ﹤0.01% | 3331 |
|
|
2025
Q3 | $55 | Hold |
23
| – | – | ﹤0.01% | 3333 |
|
|
2025
Q2 | $112 | Hold |
23
| – | – | ﹤0.01% | 3202 |
|
|
2025
Q1 | $34 | Hold |
23
| – | – | ﹤0.01% | 3291 |
|
|
2024
Q4 | $44 | Hold |
23
| – | – | ﹤0.01% | 3265 |
|
|
2024
Q3 | $74 | Hold |
23
| – | – | ﹤0.01% | 3195 |
|
|
2024
Q2 | $163 | Hold |
23
| – | – | ﹤0.01% | 3060 |
|
|
2024
Q1 | $422 | Hold |
23
| – | – | ﹤0.01% | 3045 |
|
|
2023
Q4 | $247 | Sell |
23
-1
| -4% | -$12 | ﹤0.01% | 3042 |
|
|
2023
Q3 | $468 | Hold |
24
| – | – | ﹤0.01% | 3031 |
|
|
2023
Q2 | $1.81K | Hold |
24
| – | – | ﹤0.01% | 2838 |
|
|
2023
Q1 | $2.24K | Hold |
24
| – | – | ﹤0.01% | 2771 |
|
|
2022
Q4 | $2.3K | Sell |
24
-8
| -25% | -$1.16K | ﹤0.01% | 2762 |
|
|
2022
Q3 | $8K | Buy |
32
+8
| +33% | +$2.32K | ﹤0.01% | 2208 |
|
|
2022
Q2 | $4K | Hold |
24
| – | – | ﹤0.01% | 2551 |
|
|
2022
Q1 | $2K | Buy |
24
+1
| +4% | +$128 | ﹤0.01% | 2862 |
|
|
2021
Q4 | $4K | Sell |
23
-113
| -83% | -$24.8K | ﹤0.01% | 2516 |
|
|
2021
Q3 | $37K | Buy |
136
+54
| +66% | +$16.5K | ﹤0.01% | 1463 |
|
|
2021
Q2 | $33K | Hold |
82
| – | – | ﹤0.01% | 1492 |
|
|
2021
Q1 | $44K | Sell |
82
-2
| -2% | -$1.25K | ﹤0.01% | 1229 |
|
|
2020
Q4 | $32K | Buy |
84
+61
| +265% | +$24.3K | ﹤0.01% | 1277 |
|
|
2020
Q3 | $9K | Sell |
23
-3
| -12% | -$1.32K | ﹤0.01% | 1689 |
|
|
2020
Q2 | $13K | Sell |
26
-6
| -19% | -$2.67K | ﹤0.01% | 1480 |
|
|
2020
Q1 | $12K | Buy |
32
+9
| +39% | +$4.66K | ﹤0.01% | 1417 |
|
|
2019
Q4 | $17K | Hold |
23
| – | – | ﹤0.01% | 1333 |
|
|
2019
Q3 | $15K | Hold |
23
| – | – | ﹤0.01% | 1322 |
|
|
2019
Q2 | $20K | Hold |
23
| – | – | ﹤0.01% | 1205 |
|
|
2019
Q1 | $13K | Hold |
23
| – | – | ﹤0.01% | 1331 |
|
|
2018
Q4 | $7K | Hold |
23
| – | – | ﹤0.01% | 1467 |
|
|
2018
Q3 | $11K | Hold |
23
| – | – | ﹤0.01% | 1368 |
|
|
2018
Q2 | $11K | Buy |
+23
| New | +$14.6K | ﹤0.01% | 1372 |
|
|
2016
Q4 | – | Sell |
-10
| Closed | -$8K | – | 1101 |
|
|
2016
Q3 | $8K | Buy |
+10
| New | +$8.04K | ﹤0.01% | 1103 |
|
Other funds holding TCRT
BTI
AIM
KFI
NS
AF
WPA
SignatureFD's TCRT Position: Q2 2026 in Review
SignatureFD held its Alaunos Therapeutics (TCRT) position steady in Q2 2026 at 23 shares worth $52. The position accounts for ﹤0.01% of the portfolio, ranked #3458.
SignatureFD first reported a position in TCRT in Q3 2016 and has held it in 34 quarters since. The position peaked at $44K in Q1 2021. 7 funds tracked by Wall St. Rank hold TCRT as of Q2 2026.
- SignatureFD held 23 shares of Alaunos Therapeutics worth $52 as of Q2 2026.
- SignatureFD left its Alaunos Therapeutics share count unchanged in Q2 2026.
- Alaunos Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #3458 holding.
- SignatureFD first reported a position in Alaunos Therapeutics in Q3 2016 and has held it in 34 quarters since.
- SignatureFD's Alaunos Therapeutics position peaked at $44K in Q1 2021.
- 7 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2026.
Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.